Tag: biosimilars
Healthcare System Savings: How Generic Drugs Cut Billions in U.S. Drug Costs
Generic drugs saved the U.S. healthcare system $482 billion in 2024, making up 90% of prescriptions but only 12% of drug spending. Discover how generics and biosimilars are cutting costs, why brand-name drugs still dominate spending, and what’s holding back even bigger savings.